Fresenius SE Other Current Assets 2016-2024 | FSNUY

Fresenius SE other current assets from 2016 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • Fresenius SE other current assets for the quarter ending June 30, 2024 were $2.991B, a 33.2% decline year-over-year.
  • Fresenius SE other current assets for 2023 were $4.078B, a 9.59% increase from 2022.
  • Fresenius SE other current assets for 2022 were $3.721B, a 4.31% decline from 2021.
  • Fresenius SE other current assets for 2021 were $3.889B, a 15.68% increase from 2020.
Fresenius SE Annual Other Current Assets
(Millions of US $)
2023 $4,078
2022 $3,721
2021 $3,889
2020 $3,362
2019 $3,025
2018 $2,709
2017 $1,692
2016 $2,176
2015 $2,111
Fresenius SE Quarterly Other Current Assets
(Millions of US $)
2024-06-30 $2,991
2024-03-31 $3,966
2023-12-31 $4,078
2023-09-30 $40,179
2023-06-30 $4,477
2023-03-31 $4,256
2022-12-31 $3,721
2022-09-30 $4,200
2022-06-30 $4,232
2022-03-31 $3,949
2021-12-31 $3,889
2021-09-30 $3,668
2021-06-30 $3,563
2021-03-31 $3,554
2020-12-31 $3,362
2020-09-30 $3,319
2020-06-30 $2,999
2020-03-31 $3,058
2019-12-31 $3,025
2019-09-30 $2,972
2019-06-30 $2,877
2019-03-31 $2,795
2018-12-31 $2,709
2018-09-30 $2,752
2018-06-30 $2,609
2018-03-31 $2,601
2017-12-31 $1,692
2017-09-30 $2,502
2017-06-30 $2,510
2017-03-31 $2,160
2016-12-31 $2,176
2016-09-30 $2,147
2016-06-30 $2,344
2016-03-31 $2,128
2015-12-31 $2,597
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.419B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $17.788B 18.03
DaVita (DVA) United States $12.272B 15.87
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00